BC-CfE Through the Years

BC Centre for Excellence in HIV/AIDS study reveals Treatment as Prevention® combined with targeted Pre-Exposure Prophylaxis can STOP HIV/AIDS®

The BC Centre for Excellence in HIV/AIDS (BC-CfE) has released a new research study showing that the made-in-BC HIV Treatment as Prevention® (TasP® ) strategy coupled with Pre-Exposure Prophylaxis (PrEP) has dramatically reduced premature HIV/AIDS-related deaths and new HIV infections in British Columbia, Canada. The study, published in Lancet HIV, looked at the impact of

BC Centre for Excellence in HIV/AIDS study reveals Treatment as Prevention® combined with targeted Pre-Exposure Prophylaxis can STOP HIV/AIDS® Read More »

BC Centre for Excellence in HIV/AIDS announces the virtual end of the domestic HIV epidemic in British Columbia

December 1st marks World AIDS Day and the start of Indigenous AIDS Awareness Week. Today, the BC Centre for Excellence in HIV/AIDS (BC-CfE) is proud to announce the virtual end of the domestic epidemic of HIV in British Columbia. Formerly the epicenter of the HIV/AIDS epidemic in Canada, British Columbia is now recording historically low

BC Centre for Excellence in HIV/AIDS announces the virtual end of the domestic HIV epidemic in British Columbia Read More »

BC Centre for Excellence in HIV/AIDS launches new initiative targeting sexually transmitted infections in BC

The doxycycline initiative is the first program of its kind in Canada in response to the doubling of syphilis rates since 2020 Vancouver, B.C. – The BC Centre for Excellence in HIV/AIDS (BC-CfE) is proud to announce the launch of a new Doxycycline initiative for the prevention of bacterial sexually transmitted infections including syphilis, gonorrhea

BC Centre for Excellence in HIV/AIDS launches new initiative targeting sexually transmitted infections in BC Read More »

BC Centre for Excellence in HIV/AIDS Announces New Integrated Program For Those Diagnosed With Opioid Use Disorder Living With Chronic Pain

The BC Centre for Excellence in HIV/AIDS (BC-CfE) launched an integrated program in Vancouver’s Downtown East Side for individuals living with chronic pain who are diagnosed with opioid use disorder. This program, made possible with funding from Substance Use and Addictions Program (SUAP), will provide clients with an interdisciplinary team made up of a physiotherapist,

BC Centre for Excellence in HIV/AIDS Announces New Integrated Program For Those Diagnosed With Opioid Use Disorder Living With Chronic Pain Read More »

Pharmacovigilance initiative wins award for most highly cited Clinical Science article (2018) published in AIDS

The publication “Emergent drug resistance with integrase strand transfer inhibitor-based regimens” (AIDS; June 2017) received an award for being the most highly cited full article in 2018 in the category of Clinical Science, published in AIDS. Read the article

Pharmacovigilance initiative wins award for most highly cited Clinical Science article (2018) published in AIDS Read More »

A decade of effective drug safety monitoring led by the BC-CfE

For the past 10 years, the BC-CfE Pharmacovigilance Initiative has been monitoring antiretroviral-related adverse events to protect the safety of people taking medications for HIV treatment and prevention. Read more Important contributions include publication of safety alerts, annual reports, and scientific literature, and supporting medication safety education. Read more

A decade of effective drug safety monitoring led by the BC-CfE Read More »

British Columbia’s HIV Patient Safety Initiative is launched

British Columbia’s HIV Patient Safety Initiative is launched. Funded by the Canadian Patient Safety Institute, this demonstration project developed a population-based surveillance system to monitor antiretroviral-related adverse events, and would later become BC-CfE’s Pharamcovigilance Initiative Click here to learn more about adverse drug reaction reporting

British Columbia’s HIV Patient Safety Initiative is launched Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)